User:Mr. Ibrahem/Imiquimod
 | |
| Clinical data | |
|---|---|
| Trade names | Aldara, others[1] |
| Other names | 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a698010 |
| License data | |
| Pregnancy category |
|
| Routes of administration | Topical |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | 30 hours (topical dose), 2 hours (subcutaneous dose) |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C14H16N4 |
| Molar mass | 240.310 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Imiquimod, sold under the brand name Aldara among others, is a medication used to treat genital warts, superficial basal cell carcinoma, molluscum contagiosum, and actinic keratosis.[3][4] It is applied as a cream.[4]
Common side effects include swelling, redness, skin peeling, and blistering at the site.[3] Other side effects may include headaches, nausea, and muscle pains.[4] How it works is not clear; though it dose activate certain parts of the immune system.[3]
Imiquimod was approved for medical use in the United States in 1997.[3] It is available as a generic medication.[5] In the United Kingdom 12 doses costs the NHS about 50£.[4] This amount in the United States costs about 16 USD as of 2021.[5]
References
[edit]- ^ Cite error: The named reference
drugnameswas invoked but never defined (see the help page). - ^ a b "Imiquimod topical Use During Pregnancy". Drugs.com. 29 May 2019. Archived from the original on 17 July 2020. Retrieved 14 July 2020.
- ^ a b c d e f "Imiquimod Monograph for Professionals". Drugs.com. Archived from the original on 4 March 2016. Retrieved 19 July 2021.
- ^ a b c d e BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 1352. ISBN 978-0-85711-369-6.
{{cite book}}: CS1 maint: date format (link) - ^ a b "Imiquimod Prices, Coupons & Savings Tips". GoodRx. Archived from the original on 13 November 2016. Retrieved 19 July 2021.